Before propensity score-matching (n = 1430) | ASD | After propensity score-matching (n = 888) | ASD | |||
---|---|---|---|---|---|---|
Sugammadex (n = 924) | Neostigmine (n = 506) | Sugammadex (n = 444) | Neostigmine (n = 444) | |||
Age, year (≥65) | 579 (62.7) | 310 (61.3) | 0.03 | 270 (60.8) | 261 (58.8) | 0.04 |
Body mass index, kg m−2 | 24.5 (2.7) | 25.1 (7.7) | 0.20 | 24.7 (2.7) | 24.9 (6.2) | 0.08 |
Charlson Comorbidity Index score | 4.7 (1.2) | 4.8 (1.2) | 0.07 | 4 .8 (1.3) | 4.8 (1.2) | 0.06 |
ASA physical status | ||||||
1 | 302 (32.6) | 184 (36.4) | 159 (35.8) | 151 (34.0) | ||
2 | 554 (60.0) | 289 (57.1) | 0.05 | 255(57.4) | 261 (58.8) | 0.03 |
≥ 3 | 68 (7.4) | 33 (6.5) | 0.03 | 30 (6.8) | 32 (7.2) | 0.02 |
Intraoperative rocuronium dose, mg | ||||||
≥ 50, and < 100 | 742 (80.2) | 420 (82.8) | 0.02 | 381 (85.8) | 383 (86.3) | 0.01 |
≥ 100 | 176 (19.0) | 78 (15.4) | 0.11 | 32 (7.2) | 39 (8.8) | 0.05 |
Intraoperative remifentanil dose, per 100 mcg (≥10) | 76 (8.2) | 112 (22.1) | 0.52 | 62(14.0) | 59 (13.3) | 0.02 |
Total intravenous anesthesia | 68(13.4) | 38(4.1) | 0.47 | 35(7.9) | 29(6.5) | 0.07 |
Duration of anesthesia, h | 3.9 (0.7) | 4.2 (0.8) | 0.34 | 4.1 (0.8) | 4.1 (0.7) | 0.07 |
Estimated blood loss, L | 0.15 (0.1) | 0.19 (0.1) | 0.25 | 0.2 (0.2) | 0.2 (0.1) | 0.08 |
Distance, kma | ||||||
≥ 40, and < 180 | 44(8.7) | 191(20.7) | 0.29 | 44(9.9) | 40(9.0) | 0.02 |
180≥ | 20(2.0) | 201(21.8) | 0.43 | 20(4.5) | 28(6.3) | 0.04 |
Operation by skilled surgeonb | 810 (87.6) | 407 (80.3) | 0.21 | 367 (82.7) | 382 (860.) | 0.10 |